Skip to main content

Share story

AI Science

Novo to test Anthropic's Claude Science in drug research

Novo to test Anthropic's Claude Science in drug research Image: Primary
Novo and Anthropic announced a collaboration under which Novo will test Claude Science in selected research-and-development workflows for drug discovery. The companies said they will build targeted tools for scientific tasks and biological reasoning, while Novo will also use Anthropic frontier models for AI-driven software development. Novo said the work will include data governance and human oversight; financial terms were not disclosed.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from The Next Web and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Products Policy
Products Policy

Binance seeks licensed return to Malaysia through regulatory talks

Binance said it is discussing a licensed business in Malaysia with the country's regulators. The cryptocurrency exchange is seeking a route back into a market where authorities have blocked its website and applications. The discussions concern access through a licensed operation.

Products
Products

Renesas reports ¥435,917m quarterly revenue as margin guidance softens

Renesas Electronics reported third-quarter revenue of ¥435,917m, compared with ¥335,364m a year earlier, and basic earnings per share of ¥203.47, Yahoo Finance reported. The results benefited from a recent timing business sale and profit from ongoing operations.